Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GoodRx vs TOM Weight Loss

GoodRx
Graded #125

Higher grade

vs+3.299999999999997
TOM Weight Loss
Graded #197

Lower grade

The verdict

GoodRx takes it — 69.6/100 to 66.3/100.

GoodRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGoodRx +22
80
58
Dose & formulationGoodRx +8
70
62
Clinical oversightTOM Weight Loss +21
69
90
Labs & monitoringTOM Weight Loss +4
51
55
FulfillmentGoodRx +8
81
73
Contract termsEven
55
55
GoodRx · left barTOM Weight Loss · right bar

The numbers

MetricGoodRxTOM Weight Loss
WeighScore69.6/10066.3/100
GradeCC
Scorecard rank#125#197
SemaglutideNot disclosed$199/mo (all doses, compounded)
Tirzepatide$299/mo (brand Zepbound)$249/mo (all doses, compounded)
CoverageAll 50 states2 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
GoodRx

Graded #125 · C

Strengths

  • $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
  • $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
  • Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
  • No membership fee — bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded

Where it loses points

  • Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
  • Self-pay only — does not apply toward insurance benefits or deductibles
  • Headline price applies to the lowest Foundayo dose; higher doses may cost more
  • No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
  • Pricing can change as Lilly's manufacturer coupon program evolves
TOM Weight Loss

Graded #197 · C

Strengths

  • ABOM board-certified physician (Dr. Tran Le, NPI 1194212258, verified ACTIVE)
  • Solo-physician model — every patient sees Dr. Le directly
  • Flat-rate pricing — no dose escalation surcharge
  • LegitScript badge displayed
  • No FDA Warning Letters

Where it loses points

  • Limited geographic footprint — Texas and Utah only
  • No named compounding pharmacy partner disclosed
  • Compounded medications are not FDA-approved
  • Cash-pay only, no insurance

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard